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The Effect of Growth Factors on the Corneal Stroma Extracellular Matrix 
Production by Keratocyte 
LaTia Shaquan Etheredge 
 
ABSTRACT 
 
The corneal wound healing process is a complex process, which often 
leads to the development of scar tissue with loss of transparency.  When the 
cornea is wounded, some of the viable keratocytes are activated by growth 
factors to proliferate, and repair the wound by the production of a new 
extracellular matrix (ECM) that is either normal or is disorganized (fibrotic).  The 
first part of this dissertation aims to show that the growth factors IGF-I, TGF-β, 
FGF-2, and PDGF stimulate keratocytes to synthesize different levels of 
collagens and proteoglycans and are therefore responsible for initiating the 
wound healing repair process.  FGF-2 stimulated keratocytes to proliferate but 
did not stimulate collagen production; IGF-I and PDGF stimulated keratocytes to 
proliferate and produce a collagenous ECM that could restore transparency; 
while, TGF-β stimulated keratocytes produce a fibrocollagenous ECM that is 
opaque. 
The second part of this dissertation aims to evaluate collagen fibril 
content, distribution, and orientation in the ECM deposited by keratocytes 
cultured in IGF-I, TGF-β, FGF-2, and PDGF under a layer of agarose:  a culture 
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modification that enhances the formation of ECM in vitro.  FGF-2 agarose 
cultures had little ECM and the keratocytes were in close cell contact while IGF-I, 
TGF-β, and PDGF agarose cultures had the least cell contact with an extensive 
fibrillar ECM.  This newly developed agarose overlay cell culture system 
increases ECM formation with the cell layer only when the synthesis of collagen 
is stimulated and that the ECM morphology is growth factor specific. 
Cell culture has proven to be a reliable technique to study the keratocytes 
response to trauma and disease; however, limitations exist.  Primary keratocytes 
that possess quiescent phenotype are unable to be rapidly expanded or 
subcultured without the addition of a mitogen(s).  Most commonly, keratocytes 
are cultured and passaged in the presence of fetal bovine serum (FBS), which 
activate the cells to proliferate and differentiate into fibroblasts or myofibroblasts 
as well as lose expression of their unique transparency enabling gene products.  
The third part of this dissertation aims to develop a defined culture media that 
can be used to expand and subculture keratocytes that express keratocyte 
specific markers.  Culture medium supplemented with FGF-2 combined with ITS 
was used to: expand and subculture primary bovine keratocytes while 
maintaining their expression of keratocan and to restore keratocan expression to 
bovine keratocytes expanded and subcultured with media containing 2.5% FBS.  
This dissertation shows the significance of signaling molecules in vitro to 
produce keratocyte cultures useful for understanding normal stromal biology and 
its repair process. 
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Chapter One 
Introduction 
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The Cornea 
The cornea is a uniquely transparent structure that has a powerful 
refractive surface, which produces 2/3 of the eye's total focusing power (Fig. 1).  
The cornea is void of blood supply; therefore it receives its nutrients by diffusion 
from the tear fluid and aqueous humour.  In humans, the cornea has a thickness 
of 0.5-0.8mm and a diameter of about 11.5mm. The cornea is made up of three 
distinct cellular layers that are separated by basement membranes (Fig. 2) [see 
reviews [1, 2]. The epithelial layer is the outermost region that functions as a 
barrier and to absorb oxygen and other cell nutrients located in the tear fluid.  
The stroma is the thickest layer and functions to provide the cornea with strength 
and shape. It is separated from the epithelium anteriorly by bowman’s membrane 
and from the endothelium posteriorly by descemet’s membrane, both of which 
are acellular.  The endothelial layer is a single layer of cells that pumps excess 
fluid out of the stroma.  All of these layers work together to transmit and refract 
light on the surface of the retina. 
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Figure 1.  Cornea in relationship to the eye. * Wilson, S.A. and A. Last, 
Management of corneal abrasions. Am Fam Physician, 2004. 70(1): p. 123-8. 
 
Figure 2.  Anatomy of the cornea. * Wilson, S.A. and A. Last, Management of 
corneal abrasions. Am Fam Physician, 2004. 70(1): p. 123-8. 
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Development of the Cornea 
Corneal morphogenesis results from a sequence of controlled 
developmental events.  In some lower vertebrates, the corneal epithelium 
secretes and assembles a primary stroma that is acellular and contains collagen 
types II, IX, and I.  The primary stroma is composed of one or two layers of 
orthogonal layers of fibrils and has been shown to serve as a template for the 
subsequent invasion of neural crest cells that differentiate into keratocytes.   The 
presumptive keratocytes proliferate and synthesize the secondary or mature 
stroma.  The development of the mature stroma is initiated by the swelling of the 
primary stroma that is triggered by the removal of collagen type IX from the 
primary stroma and the production of hyaluronic acid.  The stroma then 
undergoes dehydration and compaction; thus the extracellular (ECM) 
components of the stroma become more concentrated, resulting in the highly 
organized and uniform array of collagen fibrils that is transparent.  The mature 
stroma primarily consists of collagen types I and V, and proteoglycans.  
 
ECM Components of the Mature Cornea 
The transparency of a mature cornea is mostly attributed to the cornea 
stroma, which constitutes 90% of the mature corneal thickness. The cornea 
stroma is comprised of a highly organized, uniquely transparent ECM, sparsely 
populated with keratocytes.  The ECM is composed primarily of collagen types I 
and V and two major types of small leucine-rich proteoglycans; chondroitin 
sulfate (decorin) and keratan sulfate (lumican and keratocan) [2]. The collagen 
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fibrils present in the corneal stroma are heterotrophic and are arranged in 
alternate layers and are separated by proteoglycans [3, 4].  The small size of the 
proteoglycans determines the spacing of fibrils and the core proteins of the 
proteoglycans and collagen type V regulate the fibril diameter [5, 6].  Embedded 
in the corneal collagenous matrix are keratocytes.  They account for 2.4% of the 
stromal volume and are responsible for the ECM production.  They are 
characterized by a dendritic morphology and form a three-dimensional network 
by contact with their extensive processes [7-9].   
 
Collagen 
Collagen is the most abundant protein in vertebrate corneas and makes 
up approximately 80% of the total corneal protein.   There are three major 
families of collagens:  fibril-forming collagens, fibril-associated collagens with 
interrupted triple helices, and nonfibrillar collagens.   The collagen stroma 
contains collagen types I and V, which are fibril-forming and the basement 
membrane of the epithelium and endothelium contains collagen type IV, which is 
a non-fibril forming collagen.  Although there are differences among collagens, 
they all contain regions where a glycine is every third residue and are comprised 
of 3 polypeptide chains [10].    
These chains undergo extensive post- translational modifications such as 
hydroxylation, glycosylation, and disulfide formation [11]. The hydroxylation of 
selected proline and lysine residues is necessary to stabilize the triple helical 
regions and ascorbate is co-factor needed for hydrolylation [12]. 
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The disulfide bonds aid in aligning the modified polypeptide chains and initiate 
the formation of the triple helix starting at the C-terminal end.  The resultant 
procollagen molecule is comprised of a triple helical domain, which is 33% 
glycine and non helical N- and C-terminal globular regions [11]. The procollagen 
N- and C-propeptides are cleaved by enzymes:  a procollagen N-proteinase and 
procollagen a C-proteinase, respectively, producing collagen molecules that 
associate into collagen fibrils [13].  These collagen fibrils are the major 
components of most ECMs. 
 
Proteoglycans 
Proteoglycans are also part of most ECMs and are associated with 
collagen fibrils.  Proteoglycans are composed of a core protein with covalently 
linked glycosaminoglycan (GAG) chains via serine residues.  
Glycosaminoglycans are linear, repeated disaccharides that are usually sulfated 
and have a molecular weight of 10-100 kDA.   Hyaluronan is an unsulfated GAG.   
Sulfated GAGs are chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin 
sulfate, and heparan sulfate.  Proteoglycans are classified by their core proteins 
and are grouped into three major families:  modular, cell-surface, and small 
leucine-rich proteoglycans (SLRPs).   
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Modular proteoglycans contain large core proteins comprised of multiple 
and often repeating subunits and can be highly glycosylated [14].   These can be 
further divided into two subfamilies: hyalectans (versican, aggrecan, neurocan, 
and brevican), which bind hyaluronan, and lectin-binding proteoglycans (perlican, 
agrin, and testican).   The cell-surface proteoglycans are also divided into two 
subfamilies:  core proteins with a membrane-spanning domain (syndecan) and 
with a glycosyl-phosphatidylinositol (GPI) linkage (glypican).  The SLRPs are 
characterized by tandem arrays of leucine-rich repeats and the presence of at 
least one GAG side chain (Fig. 3) [15].  There are two subfamilies of SLRPs:  
dermatan/chondroitin sulfate (decorin and biglycan) and keratan sulfate (lumican, 
keratocan, and fibromodulin) proteoglycans.  Lumican and keratocan are 
important for the transparency of the cornea by regulating the spacing and 
diameter of the collagen fibrils [5, 6, 16].  
 
 
Figure 3.  Small leucine-rich proteoglycan (SLRP) structure 
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Growth Factors and Receptors 
Growth factors are cell-secreted soluble proteins that bind receptors on 
the cell surface of the same cell or in other cells [17].  There are two families of 
cell surface receptors:  receptor tyrosine kinase and G-protein-coupled receptor 
[18].  Both the receptor and growth factor may have multiple isoforms that have 
different binding affinities and functions [17].   The binding of growth factors to 
their respective receptors can promote the proliferation, migration, differentiation, 
or survival of cells during development, tissue repair, and pathologies.  The effect 
of growth factors can vary depending on when it is activated, in which cell type is 
it produced, and how it interacts with other factors such as extracellular matrix 
components.  
There are many different growth factors and the research conducted in 
this thesis has focused on insulin-like growth factor (IGF-I), transforming growth 
factor-beta (TGF-β), Fibroblast growth factor-2  (FGF-2), platelet derived growth 
factor (PDGF).  IGF-I and FGF-2 are single chain polypeptides.  IGF-I has a 50% 
amino acid homology to insulin and IGF-2, and it binds to the IGF-I receptor [18].  
FGF-2 belongs to the heparin-binding growth factor family.  FGF-2 is composed 
of 146 amino acids and binds with a low affinity to heparin and heperan- sulfate 
proteoglycans.  This association prevents the growth factor from being degraded 
and increases the affinity for 1 of 4 cell surface receptors (FGFR1-4) for FGF-2.   
Unlike IGF-I and FGF-2, PDGF is a dimer composed of two polypeptide 
chains, A and B, which can form three different isoforms (PDGF-AA, PDGF-AB, 
and PDGF-BB).  The A and B polypeptide chains are approximately 100 amino 
9 
 
acid residues long and have a 60% amino acid homology [19].  These proteins 
are cleaved intracellularly and are secreted in their active forms [19].  Each of 
these isoforms can bind to the alpha-receptor but PDGF-BB is the only isoform 
that can bind to the beta-receptor.    
There are three homodimeric mammalian isoforms of TGF-beta [20] that 
are 60-80% homologous.  The most characterized member of the family of TGF-
beta proteins is TGF-beta 1.  TGF-beta is synthesized as a precursor protein that 
requires activation into a mature form for receptor binding and subsequent 
activation of signal transduction pathways.  The TGF-beta family can bind to 
three membrane receptors:  RI, RII, and RIII.   
IGF-I, FGF-2, and PDGF act through receptor tyrosine kinases by binding 
simultaneously to two receptor chains.  After binding, the receptors and 
sometimes the ligands themselves are phosphorylated on tyrosines, thus may 
initiate multiple intracellular signaling pathways.  The major pathway associated 
with these growth factors is mitogen-activated protein kinase (MAP-Kinase).  
TGF-beta is slightly different because it acts through receptor serine/threonine 
kinases by activating a type-II receptor that recruits, phosphorylates, and activate 
type-I receptor; thus initiating the Smad-dependent signaling pathway.  
 
Wound Healing Overview 
There are three major phases of the wound healing process:  
inflammatory phase, the proliferative phase, and the remodeling phase [21, 22].  
The inflammatory phase begins immediately after wounding by the invasion of 
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lymphocytes and macrophages and is characterized by the clotting cascade.  
The cells that make up the clot and the invading cells release growth factors and 
cytokines such as PDGF and TGF-β [21-23]. Subsequently, the proliferative 
phase begins as invading fibroblasts proliferate and synthesize a new ECM [21].  
During the final remodeling phase, there is an increase in ECM production and 
breakdown.  The recently formed ECM becomes more organized and cross-
linked, eventually providing approximately 80% of the strength of the uninjured 
tissue [22].  
 
Corneal Wound Healing 
The cornea’s ability to remain transparent can be compromised when the 
cornea encounters trauma, infection, ulceration, and other pathologies.  The 
wound repair process of the cornea is similar to skin, tendon, and other tissue 
types; however, the distinct avascular nature and the uniquely organized ECM of 
the cornea cause differences in the mechanism [24, 25]. 
In a healthy cornea, there are very few resident inflammatory cells present 
[26, 27] but they have been shown to infiltrate the corneal stroma immediately 
after wounding [28, 29].  These cells along with the lacrimal gland, the 
epithelium, and the native stromal cells (keratocytes) produce the growth factors 
that are supplied to the site of injury [30].  Upon wounding, TGF-beta and IL-1 
are released from the disrupted epithelium into the stroma.  IL-1 has been shown 
to promote apoptosis of damaged keratocytes and keratocytes flanking the 
wound [31].  In addition, IL-1 increases the production of PDGF and other growth 
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factors, and activates neutrophils, which are cells that clear the wound site of 
invading bacteria and cellular debris [32].  Metalloproteinases are also released 
to further clear the wound site by degrading collagen, proteoglycans, and other 
ECM proteins [33, 34]. 
The initial stromal apoptosis and ECM degradation in the cornea is 
followed by the activation, proliferation, and migration of the remaining viable 
keratocytes into the depleted stroma, to begin to replenish the stroma.  Some of 
the activated keratocytes are initiated by growth factors to transition into 
divergent phenotypes.  FGF-2 has been found to cause keratocytes to become 
more spindle-shaped [35], increase their proliferation and migration [20], and 
promote keratan sulfate proteoglycan synthesis [35]. TGF-beta causes 
keratocytes to become myofibroblasts, which are associated with a highly fibrotic 
wound phenotype.  These cells are characterized by decreased transparency, 
which is associated with the reduction of corneal crystallins and the expression of 
the cytoplasmic protein alpha smooth muscle actin [36].  Studies have shown 
that TGF-beta also stimulates the production of additional growth factors, 
collagen and other proteins associated with the remodeling of the ECM [37].   
IGF-II has been shown to be a normal component of the stromal ECM and to be 
made by keratocytes during corneal development [38, 39]. 
The remodeling of the corneal stroma can end in corneal fibrosis or 
restoration of corneal transparency.  It has been proposed that an altered ratio of 
collagen types I and V, an altered expression of proteoglycans in the wounded 
corneal stroma, and a decrease in corneal crystallin production by keratocytes 
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may be responsible for the opacity. The reason that injured keratocytes fail to 
regenerate a well-organized ECM remains unknown.   It is probable that growth 
factors play an important role in regulating the expression of the genes needed 
for both wound healing and restoration of transparency.  
 
Causes of Blindness 
In 2004, approximately 3.6 million Americans suffered from blindness and 
vision impairment [40].  Diseases of the cornea represent a significant cause of 
blindness and vision impairment and have been shown to be the second leading 
cause of blindness in children [41, 42].  In the United States, corneal disease 
accounts for 0.7% of total number of new incidence of blindness, however, 
ophthalmic treatment of diseases affecting the cornea accounts for 25% [41].  
Keratoconus is a non-inflammatory eye disease where the cornea 
develops a conical shape.  Keratoconus is characterized by the thinning of the 
corneal stroma and is typically manifested during puberty.  In the general 
population, reported incidence are approximately 1 per 2000 [43].  In 
keratoconus corneas, the thickness of lamellae is unaltered, but the number of 
lamellae is less in normal tissue [44].  Additionally, proteoglycans and keratocyte 
density are reduced in keratoconus corneas when compared with normal 
corneas.  The biochemical analysis of the stromal matrix of the keratoconus 
cornea remains inconclusive.  
In developed countries, less than 2% of blindness is caused by corneal 
disease in children, while in the poor areas of Asia and Africa 25-50% attributed 
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to corneal scarring [45].  Eye injuries are another cause of blindness leaving 1.6 
million people blind, 2.3 million people with bilateral vision impairment, and 19 
million with unilateral blindness or vision impairment [46].  Approximately, 
750,000 of these eye injury cases will require hospitalization each year [46].   
Overall, blindness and vision impairment is a growing economical concern, with 
the projected increase of about 70% by 2020 [1]. 
 
Outline 
Corneal wound healing is a complex process of events that occurs as a 
result of the synthesis of new ECM proteins.  The ECM components produced 
during corneal wound healing can aid in regeneration or induce scar formation 
which is characterized by a disorganized corneal stroma ECM [47].  The reason 
that injured corneas fail to regenerate a normal stroma remains unknown.  It has 
been proposed that keratocytes produce an altered ratio of collagen types [48, 
49] and have an altered expression of proteoglycan types [49, 50].  However, 
these changes alone cannot fully explain corneal wound healing and the 
subsequent scar formation.   It is probable that the absence or presence of other 
ECM components, may contribute to the disorganized and opaque corneal 
stroma. 
 There are four phases of corneal wound healing:  inflammation phase, 
proliferation phase, hypercellular phase, and matrix remodeling phase.  Growth 
factors are produced primarily during the inflammation phase by lymphocytes 
and macrophages that invade the wound.  We hypothesize that the subsequent 
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phases of corneal wound healing are stimulated by specific growth factors that 
stimulate keratocytes to proliferate and produce a specific ECM.  We also 
propose that these different phases of corneal wound healing can be replicated 
in vitro by culture in serum free media containing growth factors.  
Studies have shown that TGF-β, FGF-2, and PDGF can be found in tear 
fluid where they could act on keratocytes exposed by wounds and can be made 
by the invading lymphocytes and macrophages [51, 52].  TGF-β and FGF-2 have 
also been found in corneal wounds [53].  IGF-II and IGF-I have been shown to be 
present in the normal corneal stroma [39].  
Therefore we will use serum free media containing IGF-I, TGF-β, FGF-2, 
and PDGF to activate keratocytes in vitro.  Then, we will characterize the level of 
proliferation and ECM synthesis produced by the action of these growth factors 
on keratocytes and compare this to the levels of proliferation and ECM synthesis 
seen in vivo during the hypercellular and ECM matrix restoration phases of 
corneal stroma wound healing.  As a result of this approach, we expect to be 
able to identify the growth factors that stimulate the different phases of corneal 
wound healing and replace the question marks shown in [Fig. 4] with specific 
growth factors. 
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Specific Aims 
The remainder of this dissertation will present the findings of my research 
project of understanding the effect of IGF-I, TGF-β, FGF-2, and PDGF on corneal 
stroma ECM production by keratocytes.  My first specific aim was to determine if 
insulin and IGF-I have the same effect on keratocyte proliferation and on ECM 
synthesis.  This data is discussed in the Appendix.  My second specific aim was 
evaluate the effect of IGF-I, TGF-β, FGF-2, and PDGF to stimulate keratocytes to 
proliferate and produce different ECM components.  These findings are 
summarized in Chapter Two.  My third specific aim was to evaluate collagen 
fibrils produced by keratocyte cultures in growth factors by using a novel agarose 
overlay cell culture system.  These findings are summarized in Chapter Three.  
Figure 4.  Phases of corneal stromal wound healing. 
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My fourth specific aim was to develop a defined culture medium that can be used 
to expand and subculture keratocytes that express keratocyte specific markers.  
These findings are summarized in Chapter Four.   A brief discussion of the major 
findings of my dissertation research is found in Chapter Five. 
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The effect of growth factor signaling on keratocytes in vitro and its 
relationship to the phases of stromal wound repair 
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Abstract 
Purpose:  To determine the relationship between signaling by different growth 
factors and the phases of corneal stromal wound repair. We hypothesize that the 
process involves sequential signaling, resulting first in proliferation, followed by 
extracellular matrix (ECM) synthesis. 
Methods:  The effect of IGF-I, TGF-β1, FGF-2, and PDGF on proliferation and 
ECM production by primary cultured bovine keratocytes was evaluated.   DNA 
synthesis was determined by 3H-thymidine incorporation and maximal cell 
density was determined by measuring the DNA content.  Relative levels of ECM 
components synthesized by keratocytes and secreted into the media was 
evaluated by 3H-glycine incorporation into total ECM protein and collagen, by 3H-
glucosamine incorporation into chondroitin sulfate, keratan sulfate, and 
hyaluronan, and by western blots with antibodies specific to procollagen types Ι 
and ΙΙΙ.  
Results:  FGF-2 stimulated the highest level of proliferation, the lowest level of 
glycosaminoglycan synthesis, and inhibited the synthesis of collagen collagen 
types Ι and ΙΙΙ.  IGF-I, in contrast, stimulated the lowest level of proliferation and 
the highest levels of collagen synthesis.  PDGF and TGF-β1 had intermediate 
effects on proliferation and collagen synthesis.  Although FGF-2 inhibited 
collagen production, it could be restored by subsequent treatment with IGF-I, 
TGF-β1, and PDGF. 
 Conclusions:  The results of this study showed that the levels of proliferation 
induced by the growth factors were inversely related to the level of collagen 
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production. We suggest that FGF-2 initiates the hypercellular phase of corneal 
wound healing, while IGF-I and PDGF are involved in the restoration of a normal 
ECM. 
 
Introduction 
The mature corneal stroma consists of a distinctively organized and 
transparent extracellular matrix (ECM) which is comprised of mainly fibrillar 
collagen types Ι and V, and three of small leucine-rich proteoglycans; one with 
chondroitin sulfate chains (decorin) and two with keratan sulfate chains (lumican 
and keratocan).  Collagen is present in the corneal stroma as fibrils that are 
separated by small spaces containing proteoglycans and are arranged in 
plywoodlike layers.  Collagens play a fundamental role in the structure and 
function of the cornea.  The organization of fibrils and lamellae, as well as the 
crosslinking of the collagen provide the cornea with its tensile strength while the 
uniform diameter and spacing of the collagen fibrils provide the cornea with its 
ability to transmit light onto the retina [for reviews see [2, 54, 55].  Collagen type 
V initiates fibril formation and acts in conjunction with lumican and keratocan and 
decorin to regulate fibril diameter growth [3, 6, 56-59].  Type ΙΙΙ collagen also has 
been reported to be normally present in bovine and rabbit corneas [60, 61].  More 
recent studies in mice suggest collagen type ΙΙΙ may be developmentally 
regulated and expressed primarily in neonatal corneas [62]. 
Embedded in this unique ECM are keratocytes, neural crest-derived cells 
that produce the proteoglycans and collagens [63].  Keratocytes are 
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characterized by a dendritic morphology and form a three-dimensional network in 
contact with one another by their extensive processes [63, 64].  Keratocytes 
proliferate and are biosynthetically active during corneal development. In adult 
corneas, they are considered quiescent because they are locked in G-0 of the 
cell cycle [65] and they have a low level of proliferation and matrix synthesis [54, 
63, 66].  Keratocytes also are characterized by high levels of crystallins 
(aldehyde dehydrogenase and transketolase) in their cytoplasm, which are 
proteins that are thought to provide cellular transparency [67]. 
The cornea’s ability to remain transparent can be compromised when the 
cornea encounters trauma, infection, ulceration, or chronic corneal inflammation.  
Upon injury, damaged keratocytes and keratocytes flanking the wound undergo 
apoptosis [66, 68].  Some of the remaining keratocytes are stimulated to lose 
their quiescence and transition into divergent or “activated” phenotypes, which 
proliferate, resulting in regions of hypercellularity that then go on to produce the 
new matrix needed to repair the wound [4, 66, 69, 70].  These divergent 
phenotypes can either aid in regeneration of a normal stromal matrix or become 
a scar by remaining hypercellular or producing a disorganized matrix [47, 71].  It 
has been proposed that an altered ratio of collagen types and proteoglycans in 
the ECM and/or the loss of the “crystallins” from the keratocytes cause the 
opacity [48, 49, 67, 72]. 
Peptide growth factors, extracellular signal proteins (ligands), which 
promote the growth, proliferation, and differentiation of cells in animal tissues by 
interacting with cell-surface receptors are partially credited for the regulation of 
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collagen and proteoglycans expression during corneal wound healing [73].  
Growth factors are able to reach the wound site through tear film, aqueous fluid, 
and the epithelial layer of the cornea [73] [74, 75].  Insulin-like growth factor-II 
(IGF-II) has been shown to be present in the aqueous humor and in the cornea 
[38, 76].  Both insulin-like growth factor-I (IGF-I) and IGF-II, which act on the 
same receptors, have been shown to cause keratocytes to proliferate and 
maintain their dendritic morphology in vitro [38, 75].  Transforming growth factor-
beta (TGF-β), fibroblast growth factor-2 (FGF-2), and platelet-derived growth 
factor (PDGF) have all been found in tear fluid [51, 52]. These growth factors can 
activate keratocytes to proliferate, differentiate into fibroblasts or myofibroblasts, 
and migrate, similar to that of in vivo keratocyte response to injury [69, 75, 77, 
78].   
Although a number of studies have reported the effect of growth factors on 
keratocyte morphology, crystallin content, alpha smooth muscle actin expression, 
and proteoglycan synthesis [35, 36, 38, 75, 77, 79-81]; comparatively, little 
attention has been given to their effect on collagen synthesis [37, 82], which is 
the single most important structural element of the cornea.  Consequently, in this 
study, we analyzed the effects of different growth factors (IGF-I, TGF-β1, FGF-2, 
and PDGF) on keratocyte proliferation and matrix synthesis to test our 
hypothesis that stromal wound healing involves sequential signaling leading to 
keratocyte proliferation followed by extracellular matrix synthesis and deposition. 
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Materials and Methods 
Chemicals, growth factors, papain, and hyaluronate lyase were purchased 
from Sigma-Aldrich (St. Louis, MO) unless otherwise stated.  Isotopes were 
purchased from Perkin Elmer (Boston, MA).  CyQuant kit, gels, reagents, and 
equipment that were used for protein separation and transfer were purchased 
from Invitrogen (Carlsbad, CA).  Endo-beta-galactosidase and chondroitinase 
ABC were purchased from Associates of Cape Cod (East Falmouth, MA) 
Collagenase Form III for measuring 3H-glycine incorporation into collagen was 
purchased from Advanced Biofactures Corp. (Lynbrook, NY) 
  
Keratocyte isolation and culture 
Bovine keratocytes were collagenase-isolated as previously described [35, 
50].  In brief, freshly harvested corneas were obtained from 12-month old calves 
and sequentially digested.  Initially, the tissue was subjected to a 45-minute 
collagenase digestion to remove the endothelium and epithelium and then 
keratocytes were released from the stroma by a second 150-minute digestion.  
Keratocytes were plated in serum- free DMEM/F12 containing antibiotics and 
1mM 2-phospho-ascorbic acid at 20,000 cells/cm2 to allow attachment (day 0) 
and incubated at 37°C with 5% CO2.  Medium was changed the next day (day 1) 
and every third day thereafter with DMEM/F12 or DMEM/F12 supplemented with:  
10 ng/ml IGF-I, 2 ng/ml TGF-β1, 10 ng/ml FGF-2, or 10 ng/ml PDGF-BB.  
Cultures were harvested on days 1,7,10, and 13. 
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DNA content 
DNA was extracted from the cell layers of each well of harvested cultures 
using cyquant buffer.  DNA in the extract was measured using a Cyquant Assay 
Kit consistent with the manufacturer’s instructions and expressed as ng 
DNA/well.  Calf thymus DNA was used as a standard. 
 
Radiolabeling of keratocytes 
Keratocytes were incubated with 10 µCi/ml 3H-thymidine for DNA 
synthesis or 25 µCi/ml 3H-glycine for protein/collagen synthesis, beginning on 
days 4, 7, and 10 then harvested 3 days later.  Keratocytes were also incubated 
with 25 µCi/ml 3H-glucosamine for glycosaminoglycan synthesis beginning on 
day 7 and harvested on day 10.  
DNA synthesis.  Incorporation of 3H-thymidine into DNA was determined as 
previously described [35].  In summary, aliquots of cyquant buffer extract of the 
cell layer was adjusted to contain 10% trichloricacetic acid (TCA), carrier protein 
bovine serum albumin (BSA) was added and the mixture held at 4°C overnight to 
precipitate DNA.  The precipitate was collected onto glass filters and the 
unincorporated isotope was removed by washing with ice-cold 5% TCA.  
Incorporation was measured by liquid scintillation counting and expressed as 
counts per minute/ng DNA. 
Protein/collagen synthesis.  Incorporation of 3H-glycine into collagen and total 
protein secreted into the media was measured as previously described [12].  
Briefly, unincorporated radioactivity was removed by chromatography on PD-10 
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columns in 4 M guanidine-HCl.  The guanidine was removed by dialysis against 
water.  Aliquots of 400 µl were incubated with 1mg of papain in papain digestion 
solution (PBS containing 10mM cysteine and 10mM EDTA) then, digested for 3 
hours at 55°C, precipitated with 10% TCA and the supernatant counted to 
determine incorporation of 3H-glycine into total protein.  Additional 400 µl aliquots 
were digested with collagenase at 37°C for 3 hours in collagenase digestion 
solution (3 mM N-ethly maleimide, 50 mM Tris, 150 mM NaCl, and 5 mM CaCl2) 
and processed as described for papain digests, to determine incorporation into 
collagen. The incorporated radiolabeled radioactivity in collagen and in total 
protein were expressed counts per minute/ng DNA. 
Glycosaminoglycan synthesis.  Incorporated 3H-glucosamine secreted in the 
medium was isolated by chromatography on PD-10 columns in 4 M guanidine 
and dialyzed against distilled water overnight. Aliquots were digested with:  H2O 
(blank), chondroitinase ABC (.05 U/µl), endo-beta-galactosidase (.5 mU/ µl), and 
hyaluronate lyase (ampule dissolved in 250 µl of H2O, used 5 µl/sample), for 3 
hours at 37°C.  Undigested GAGs were precipitated out by the addition of 2% 
dextran sulfate and 1% KAc in 95% ETOH at 4°C.  The precipitate was removed 
by centrifugation and the radioactivity of the supernatant was measured by liquid 
scintillation spectrophotometry. Chondroitinase ABC digests both CS and HA, 
therefore, the amount of HA was subtracted from the amount of CS to determine 
CS content. The incorporated radioactivity in CS, KS, and HA was expressed per 
µg DNA. 
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SDS/PAGE/Simply-blue stain 
Medium was collected from each condition and concentrated 10-fold using 
10 000 MWCO Amicon Ultra spin-concentrators (Millipore Corp., Millford, MA).  
Samples were loaded based on DNA content and electrophoresed under 
reducing conditions on 3-8% tris-acetate acrylamide gels.  Gels were stained with 
Simply Blue Safe Stain according to the manufacturer’s instructions. 
 
Pepsin digestion 
Eight milliters of medium pooled from 4 wells was adjusted to 0.5 M acetic 
acid by the addition of 230 µl of glacial acetic acid.  Two milliliters of 0.5 M acetic 
acid was added to each of the 4 wells. A pepsin stock solution (4mg/ml of 0.5 N 
acetic acid) was prepared and, after the samples had chilled to 4°C, 100 µl of the 
stock was added to the medium and 25 µl of the stock was added to each well.  
The samples were digested overnight at 4°C.  The cell layer samples were 
combined and 50 µl of pepsin stock was added to the cell layer samples and 
digested for an extra 5 hours at 4°C.  The samples were adjusted to neutrality 
with NaOH to inactivate pepsin.  Samples were dialyzed against water, 
lyophilized, and reconstituted in 1X LDS sample buffer.  Samples were loaded 
based on DNA content, determined on parallel cultures, to 3-8% tris-acetate gels 
and electrophoresed as described above. 
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Western blotting 
Proteoglycan levels, fibronectin levels and procollagen levels in the media 
were determined by western blot as described previously [35].  Medium was 
digested with endo-beta-galactosidase to detect keratocan and lumican core 
proteins, or with chondroitinase ABC to detect decorin and biglycan core 
proteins.   All samples were loaded based on DNA content and electrophoresed 
as described above.  Proteins were transferred to a nitrocellulose membrane, 
and then blocked with I-Block solution.  The primary antibodies were added at 
4°C overnight:  keratocan [50], lumican [50], decorin (DS1, Hybridoma Bank, U. 
of Iowa), biglycan (gift from Dr. Larry W. Fisher), extra domain A (EDA) 
fibronectin (Accurate Chemical & Scientific Corp., Westbury, NY), fibronectin 
(Chemicon International, Temecula, CA), procollagen type Ι (SP1.D8, Hybridoma 
Bank, U. of Iowa) or procollagen type ΙΙΙ (US Biological, Swampscott, MA).  The 
corresponding secondary was added, which is horseradish peroxidase tagged, 
and then detected using the ECL detection kit consistent with manufacture’s 
instructions.     
 
Statistics 
All DNA values were the mean of 3 or 4 determinations. 3H-thymidine 
incorporation values were the mean of 4 determinations. 3H-glucosamine 
incorporation values were the mean of 3 determinations.  All other values shown 
were based on a single determination but all experiments were conducted 2 or 
more times using different batches of primary cells and the results of a 
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representative experiment is shown.  Statview Version 5 (SAS Institute, Cary, 
NC) was used for statistical comparisons.  Samples were analyzed using a 
paired t test.  Standard error used n>3 and standard deviation was used when 
n=3.   
 
Results 
Each growth factor stimulated a different rate of keratocyte proliferation.  
Cells were incubated with media containing 3H-thymidine for three days, 
beginning on days 4, 7, and 10, and incorporation per ng DNA was determined 
on days 7, 10, and 13 (Fig. 5A).  All of the growth factors significantly stimulated 
higher levels of incorporation relative to the control for all three-time points 
except for IGF-I on day 10.  At day 7, FGF-2 stimulated incorporation the most 
and IGF-I the least with TGF-β1 and PDGF stimulating intermediate levels of 
incorporation.  Incorporation in the FGF-2 treated cultures decreased from day 7 
to 10, to be levels lower than that of TGF-β1 and PDGF but still higher than that 
of IGF-I.  Each of the growth factors stimulated the highest levels of incorporation 
on day 7, except TGF-β1, which stimulates the greatest incorporation on day 10. 
Growth factors differentially increased keratocyte culture density. The 
DNA content of the keratocyte cultures were measured on days 1, 7, 10, and 13 
to determine if cultures treated with each of the growth factors increased the cell 
number (Fig. 5B).  The DNA content of the control on day 1 was not significantly 
different from the control on day 7 (data for day 1 control not shown on figure).  
The DNA content of the control and growth factor treated cultures were 
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significantly different on day 7:  FGF-2 was 3.2-fold higher than control, PDGF 
was 2.0-fold higher, TGF-β1 was 1.8-fold higher, and IGF-I was 1.6-fold higher.  
The DNA content for the control and growth factor treated cultures on days 10 
and 13 followed the same pattern as day 7.    
Dermal fibroblasts and keratocytes in standard monolayer culture do not 
readily remove the N-and C-terminal globular domains on the procollagen they 
synthesize.  Procollagen cannot form collagen fibrils that would associate with 
the cells and as a result, the procollagen is secreted into the media [83, 84].  In 
the absence of collagen fibrils, the proteoglycans and other components of the 
ECM that associate with collagen fibrils are also secreted into the media.  
Therefore, the media was analyzed for the components of the ECM.  Each 
growth factor stimulated a different level of total ECM protein and collagen 
synthesis.  Keratocytes were cultured in media containing 3H-glycine for 3 days 
beginning on days 4, 7, and 10.  The sensitivity of the incorporated radiolabel 
secreted into the media to papain and to collagenase was used to determine the 
amount of total ECM protein synthesis and collagen synthesis, respectively. 
The results show that compared to controls, IGF-I, TGF-β1, and PDGF 
stimulated incorporation into total ECM protein from as little as 4.0-fold for TGF-
β1on day 7, to as much as 15-fold for IGF-I on day 13.  Keratocytes cultured in 
IGF-I synthesized the highest levels of total ECM protein; FGF-2 the lowest; 
while PDGF and TGF-β1 had intermediate levels of total ECM protein synthesis, 
for all three-time points (Fig. 6A).  The levels of total ECM protein synthesized by 
the keratocytes cultured in IGF-I, TGF-β1, and PDGF increased from day 7 to 10 
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and from day 10 to13 and increased the most in the TGF-β1 treated cultures.  
The levels of collagen synthesis followed the same pattern as the total ECM 
protein synthesis, but was ~20-40% lower (Fig. 6B).   
The proteins that were secreted into the medium by keratocytes also were 
evaluated by SDS/PAGE/simply-blue staining. Analysis of DNA-normalized 
aliquots from day 10 cultures showed that each of the tested growth factors 
caused keratocytes to secrete proteins in the medium that produced a similar 
banding pattern, but the band intensity was growth factor dependent (Fig. 7). 
IGF-I and TGF-β1 treated cultures secreted the most proteins, FGF-2 the least 
and PDGF secreted intermediate levels of proteins. Compared to day 10 
cultures, the band intensity of proteins in the medium was less in samples from 
day 7 cultures and greater in samples from day 13 cultures, but the banding 
pattern for each of the growth factors was comparable at all three time points 
(data not shown).  These results suggest that IGF-I, TGF-β1, PDGF, and FGF-2 
stimulate the cells to secrete essentially the same matrix proteins into the media; 
however, the expression levels of the proteins are growth factor specific. 
The major proteins secreted into the media were identified using western 
blotting.  We analyzed DNA-normalized aliquots of media harvested at day 10, 
for EDA fibronectin, an isoform of fibronectin found after wounding [85], and 
fibronectin.  Antisera to EDA fibronectin reacted with a single band of 210 kD 
present in the media (Fig. 8A).   This protein was most abundant in the media of 
TGF-β1treated cultures with lesser amounts in the media of cultures treated with 
the other growth factors and only trace amounts in media from controls.  A 
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western blot using an antibody that recognizes all forms of fibronectin, including 
EDA fibronectin, indicated that the levels of fibronectin produced by the control 
were similar to that of the FGF-2 treated cultures (Fig. 8B).  The blue staining 
band at 210 kD in Figure 3 is likely to be fibronectin and is identified as FN.   
Western blot analysis using an antibody specific for type Ι procollagen on 
DNA-normalized aliquots of medium from day 10 of culture, demonstrated that 
type Ι procollagen was readily detected in the medium of keratocytes cultured in 
IGF-I, TGF-β1, and PDGF (Fig. 9A).  When compared to control, IGF-I, TGF-β1, 
and PDGF stimulated the production of type I procollagen while FGF-2 inhibited 
the production of type I procollagen.   The production of type ΙΙΙ procollagen by 
growth factor treated cultures also was evaluated by western blot using an 
antibody specific for type ΙΙΙ procollagen.  Compared to control, type ΙΙΙ 
procollagen was stimulated to the greatest extent in cultures treated with IGF-I 
and TGF-β1 and was inhibited in cultures treated with FGF-2 (Fig. 9B).  The 
major blue staining bands that react with these antibodies are identified in Figure 
3 as proα1(Ι)(ΙΙΙ) and pNα(Ι)(ΙΙΙ).  
Fibril-forming collagen (types Ι and ΙΙΙ) content in the media and cell layer 
from day 10 cultures was determined by pepsin digestion and SDS/PAGE/simply 
blue staining (Fig. 10).   Pepsin readily degrades globular proteins under acidic 
conditions, but those regions of collagen molecules that form a stable triple helix 
are resistant to this protease.  Keratocytes cultured in IGF-I had the highest 
levels of fibrillar collagen in the media. TGF-β1and PDGF induced production of 
intermediate amounts of collagen deposited into the medium. Medium from FGF-
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2 treated cultures had levels of fibrillar collagen similar to that of the control.  
Fibrillar collagen associated with the cell layer was seen only in the TGF-β1 
treated cultures.  
Glycosaminoglycan synthesis by cultured keratocytes in response to the 
different growth factors also was evaluated.  Cells were radiolabeled with 3H-
glucosamine from days 7 to 10 and the glycosaminoglycans secreted into the 
media were digested with chondroitinase ABC, endo-beta-galactosidase, or 
hyaluronate lyase to determine the relative levels of chondroitin sulfate, keratan 
sulfate, and hyaluronan synthesis, respectively.  The results show that when 
compared to control, cultures treated with TGF-β1 and PDGF synthesized the 
highest levels of chondroitin sulfate and FGF-2 the least (Fig. 11A).  
Furthermore, cultures treated with PDGF and IGF-I produced the highest levels 
of keratan sulfate synthesis while FGF-2 did not stimulate keratan sulfate 
synthesis (Fig. 11B).  Hyaluronan synthesis was 20-fold higher than the control 
in keratocytes cultured in media containing TGF-β1 (Fig. 11C). These data 
indicate that the levels of glycosaminoglycan synthesis stimulated by each of the 
growth factors generally follows the pattern of total ECM protein synthesis. 
Western blot analyses with antibodies to the core proteins of decorin and, 
biglycan, or keratocan, and lumican, respectively were performed.  Aliquots of 
media harvested on day 10 from keratocytes cultured in each of the growth 
factors were normalized for DNA content, digested with either chondroitinase 
ABC or endo-beta-galactosidase and analyzed (Fig. 12).  Decorin and keratocan 
production was stimulated by all of the growth factors.  Lumican production was 
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only stimulated by IGF-I.  Biglycan was only detected in media from keratocytes 
cultured in TGF-β1.  
FGF-2 induced proliferation the most, a hallmark of the initial phase of 
wound healing, but inhibited the synthesis of procollagen Ι, which is essential for 
a corneal reconstruction.   Therefore, we determined if keratocytes that have 
been cultured in FGF-2 could still respond to other growth factors that stimulate 
collagen synthesis and up-regulate procollagen type Ι synthesis.  Keratocytes 
were treated with FGF-2 for 7 days, followed by 6 days of treatment with DMEM 
F/12, IGF-I, TGF-β1, FGF-2, or PDGF.  DNA content of the cell layer and type Ι 
procollagen in the medium were determined (Fig. 13).  The DNA content of 
cultures continually treated with FGF-2 significantly increased from day 1 (C1) to 
day 7 (F7), and then declined a small amount from day 7 (F7) to day 13 (F-F).  
Compared to continuous culture in FGF-2 (F-F), cultures switched to PDGF (F-P) 
and the IGF-I (F-I) had significantly higher DNA content (Fig. 13A).  Aliquots of 
medium normalized for DNA content were analyzed using western blots with the 
antibody to type Ι procollagen (Fig. 13B).  Type Ι procollagen levels in the media 
of keratocytes treated with FGF-2 for 7 days (F7) and 13 days (F-F) were less 
than the controls (C7 and C13) but cultures switched to IGF-I (F-I), TGF-β1 (F-T), 
and PDGF (F-P) showed increased type Ι procollagen levels. 
 
Discussion 
When the cornea stroma is wounded, injured keratocytes and keratocytes 
surrounding the wound undergo apoptosis [66, 86].  Proliferation by some or all 
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of the remaining cells would be essential to replace the cells lost due to 
apoptosis.   The results of this study show, IGF-I, TGF-β1, FGF-2, and PDGF 
stimulate different rates of DNA synthesis and different levels of maximal cell 
density.  FGF-2 treated keratocytes synthesized DNA at the highest rate at the 
day seven time point and reached the highest level of maximal cell density.  
PDGF treated keratocytes synthesized DNA at a lower rate at the day 7 time 
point but then exceeded FGF-2 at the days 10 and 13 time points and eventually 
achieved nearly the same cell density as cells treated with FGF-2. Keratocytes 
treated with TGF-β1 synthesized DNA at a rate similar to PDGF and achieved 
the third highest level of maximal cell density.  IGF-I treated keratocytes had the 
lowest rate of DNA synthesis and lowest level of maximal cell density. These 
results indicate that, for these growth factors the level of maximal cell density 
achieved is related to the rate of DNA synthesis induced by that growth factor.  
All of these growth factors, however, would be potential candidates for regulatory 
roles in controlling proliferation involved in the hypercellular phase of corneal 
stromal wound healing.  
The synthesis of an ECM containing collagen is essential subsequent to 
proliferation in restoring the integrity of the corneal stroma after wounding.  The 
results of this study show that IGF-I, TGF-β1, and PDGF stimulate significantly 
different levels of collagen synthesis; IGF-I stimulated higher levels of collagen 
synthesis than did TGF-β1and PDGF.  FGF-2 did not stimulate collagen 
synthesis.  This same pattern was observed in: 3H-glycine labeling for total ECM 
proteins and collagenous proteins, simply blue staining of matrix proteins, 
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western blots with antibodies to types Ι and ΙΙΙ procollagen, and levels of 
collagenous proteins revealed by pepsin digestion of the medium.  The level of 
collagen synthesis induced by each of the growth factors is, then, inversely 
related to the level of confluence achieved by keratocytes cultured in that growth 
factor.  
In addition to the collagens, the proteoglycans and glycoproteins play a 
major role during wound healing.   Keratan sulfate proteoglycans are normally 
present in the corneal stroma at high levels and function to direct collagen 
assembly.  In contrast, hyaluronan is only present in mature corneas during 
wound healing and may reduce transparency by disrupting the spacing of 
collagen fibrils [4, 87].  We found that while all of the growth factors stimulated 
chondroitin sulfate synthesis, FGF-2 stimulated its synthesis the least.  FGF-2 
was also the only growth factor that did not stimulate keratan sulfate synthesis. 
TGF-β1 treatment, however, also stimulated the synthesis of biglycan and 
hyaluronan, known markers of ECM scarring [4, 88, 89]. 
In addition, TGF-β1stimulated the highest levels of EDA fibronectin and 
the greatest amount of collagen associated with the cells.  Fibronectin is known 
to assist in the formation of ECM by enhancing the conversion of procollagen to 
collagen [11].  These results suggest that in addition to stimulating the synthesis 
of collagens, IGF-I and PDGF also stimulated the synthesis of the collagens, 
proteoglycans, and glycoproteins that more closely resemble normal corneal 
stromal composition. Therefore, regeneration of normal stroma after injury is 
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likely to involve these growth factors while production of a scar-type ECM would 
involve TGF-β1.  
Although FGF-2 stimulated keratocytes to proliferate at high levels and 
also stimulated the production of decorin and chondroitin sulfate, it did not 
stimulate the synthesis of collagenous proteins.  Western blots, however, 
indicated that FGF-2 actually inhibited the synthesis of types Ι and ΙΙΙ 
procollagen.  The ECM produced by FGF-2 action on keratocytes would consist 
of essentially proteoglycans and fibronectin, and without collagen it would lack 
tensile strength.  We also showed that the FGF-2 mediated inhibition of type Ι 
procollagen synthesis could be reversed by subsequent culture in media 
containing the growth factors that stimulate collagen synthesis, IGF-I and PDGF, 
growth factors that also stimulate the synthesis of the normal proteoglycans. This 
indicates that the inhibition of type Ι procollagen synthesis by FGF-2 was not a 
permanent phenotypic change. 
In conclusion, we suggest that stromal wound healing occurs as a result of 
the sequential action of growth factors on keratocytes (Fig. 14).  Quiescent 
keratocytes are activated to proliferate upon wounding to create regions of 
hypercellularity that consist of densely packed cells with a sparse or provisional 
matrix that contains keratocan [30, 70, 71].  We found that while FGF-2 
stimulated proliferation and chondroitin sulfate synthesis, it did not stimulate 
keratan sulfate synthesis and it inhibited procollagen types Ι and ΙΙΙ synthesis.  
This low level of total ECM synthesis by FGF-2 activated keratocytes would 
result in a sparse matrix. 
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Thus, we speculate that the regions of hypercellularity that are seen 
during the initial phases of wound healing are keratocytes that have been 
activated by FGF-2.  In vivo, the provisional matrix in regions of hypercellularity 
can be replaced by a fibrillar matrix.  We also observed that collagen synthesis 
can be restored to FGF-2 activated keratocytes by subsequent culture in media 
containing IGF-I, TGF-β1, and PDGF.  Thus, we further speculate that IGF-I or 
PDGF could be acting on the hypercellular keratocytes to make them become 
collagenous keratocytes.  These collagenous keratocytes replace the provisional 
matrix with a normal fibrillar matrix that restores stromal integrity and then the 
keratocytes later become quiescent again. TGF-β1 also restored collagen 
synthesis to FGF-2 activated keratocytes but this growth factor also stimulated 
the synthesis of biglycan and hyaluronan, markers of fibrosis. 
We propose; therefore, that TGF-β1would cause the hypercellular 
keratocytes to become fibrobrocollagenous keratocytes and produce a scar-type 
fibrillar matrix. TGF-β1has also been shown to cause keratocytes to become 
myofibroblasts, based on the appearance of α smooth muscle actin [36].  
Keratocytes made myofibroblastic by TGF-β1would be synonymous with 
fibrocollagenous keratocytes.  The absence of any subsequent growth factor 
would result in a hypercellular scar. The targeted modulation of these signaling 
molecules has considerable clinical relevance. 
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Figure 5.  Keratocyte DNA Synthesis and cell density.  Keratocytes were cultured in 
DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or 
PDGF.  A:  Keratocyte DNA Synthesis.  Cultures were radiolabeled with 3H-thymidine 
on days 4-7, 7-10, and 10-13, the incorporation determined and expressed per ng 
DNA.  Compared to control, IGF-I, TGF-β1, FGF-2, and PDGF significantly (p< 
0.011) increased 3H-thymidine incorporation at all three-time points, except for IGF-I 
on day 10.  B:  Keratocyte Density.  DNA content of keratocyte cultures measured on 
days 7,10, and 13.  Keratocytes cultured with IGF-I, TGF-β1, FGF-2, and PDGF 
contained significantly (p<0.044) more DNA than the control, for all three-time points.  
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Figure 6.   Protein and collagen synthesis by keratocytes in culture.  Keratocytes 
were cultured with DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I, 
TGF-β1, FGF-2, or PDGF and radiolabeled with 3H-glycine on days 4-7, 7-10, and 
10-13.  The sensitivity of the incorporated radiolabel secreted in the media to 
papain (A:  Total Protein) and to collagenase (B:  Collagenous protein) was 
determined and expressed per ng DNA. 
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Figure 7.  Simply-blue stainable proteins secreted into the medium by keratocytes 
in culture.  Keratocytes were cultured with DMEM/F12 (Control) or DMEM F/12 
supplemented with IGF-I, TGF-β1, FGF-2, or PDGF.  The medium from the 7-10 
day time period was harvested and analyzed by SDS/Page.  The bands later 
identified by western blot in Figs 4 and 5 are labeled:  fibronectin [FN], procollagen I 
[proα1(Ι) and pNα1(Ι)], and procollagen ΙΙΙ [proα1(ΙΙΙ) and pNα1(ΙΙΙ)]. 
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Figure 8.  Western blots of media from day 10 keratocyte cultures using 
antibodies to EDA fibronectin for EDA fibronectin (A) and to fibronectin for total 
fibronectin (B).  Keratocytes were cultured with DMEM/F12 (Control) or DMEM 
F/12 supplemented with IGF-I, TGF-β1, FGF-2, or PDGF.  The bands detected by 
these antibodies correspond to the bands marked FN on figure 3. 
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Figure 9.  Western blots of media from day 10 keratocyte cultures using antibodies to 
procollagen type Ι (A) and procollagen type ΙΙΙ (B).  Keratocytes were cultured with 
DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or 
PDGF.  The bands marked proα1(Ι), proα1(ΙΙΙ), pNα1(Ι), and pNα1(ΙΙΙ), corresponds 
to the migration position of the band marked proα1(Ι)(ΙΙΙ) and pNα1(Ι)(ΙΙΙ) on figure 3.  
The migration position of pepsin digested collagen types Ι and ΙΙΙ are marked as 
α1(Ι),α2(Ι), and α1(ΙΙΙ), respectively. 
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Figure 10.  Fibrillar collagen present in the medium and cell layer of day 10 
keratocyte cultures.  Keratocytes were cultured with DMEM/F12 (Control) or 
DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or PDGF.  Cultures were 
harvested on day 10 and samples were digested with pepsin prior to 
electrophoresis.  A pepsin alone control was added (Pepsin).  The migration 
position of the α1(Ι), α2(Ι) and α1(ΙΙΙ) chains of collagen are marked. 
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 Figure 11.  Glycosaminoglycan synthesis by keratocyte cultures.  Keratocytes 
were cultured with DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-
I, TGF-β1, FGF-2, or PDGF and radiolabeled with 3H-glucosamine on days 7-10.  
The incorporated radiolabel secreted in the media was then characterized by its 
sensitivity to chondroitinase ABC for chondroitin sulfate (A), to endo-beta-
galactosidase for keratan sulfate (B), and hyaluronan lyase for hyaluronan (C).  
When compared to control, the synthesis of chondroitin sulfate (A) was 
significantly (p<0.008) higher in cultures treated with each of the growth factors; 
keratan sulfate (B) was significantly (p<0.012) higher in TGF-β1, FGF-2, and 
PDGF treated cultures; and hyaluronan (C) was significantly (p<0.05) higher in 
cultures treated with TGF-β1, FGF-2 and PDGF. 
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Figure 12.  Western blots of medium from day 10 keratocyte cultures 
using antibodies to decorin, biglycan, keratocan, and lumican. 
Keratocytes were cultured with DMEM/F12 (Control) or DMEM F/12 
supplemented with IGF-I, TGF-β1, FGF-2, or PDGF.  Media was digested 
with chondroitinase ABC, for decorin and biglycan, or endo-beta-
galactosidase, for keratocan, and lumican, prior to electrophoresis. 
 
45 
 
Figure 13.  DNA content and procollagen type Ι production of keratocytes 
cultured first with FGF-2 and then changed to each of the growth factors.   
Keratocyte were cultured with FGF-2 for 7 days (F7), then medium was changed 
to DMEM F/12 (F-C) or DMEM F/12 supplemented with IGF-I (F-I), TGF-β1 (F-T), 
FGF-2 (F-F), or PDGF (F-P) and the keratocytes cultured for 6 additional days.  
Keratocytes cultured with DMEM/F12 on days 1 (C1), 7 (C7), and 13 (C13) were 
used as controls.  A:  Keratocyte density.  DNA content of keratocytes cultured 
with FGF-2 for 7 days was significantly (p<0.0001) higher than the day 7 control.  
Keratocytes cultured in FGF-2 for 7 days and then switched to PDGF (F-P) or to 
IGF-I (F-I) had significantly (p<0.025) higher DNA content than keratocytes 
continuously cultured in FGF-2.  B:  Procollagen type Ι.  Western blot using an 
antibody to procollagen type Ι of media harvested on days 7 and 13 of culture. 
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Figure 14.  Schematic representation of possible growth factor mediated wound 
healing of the corneal stroma.  Upon wounding, quiescent keratocytes are 
activated by FGF-2 to become hypercellular:  keratocytes that proliferate and 
synthesize a provisional matrix, a matrix that lacks collagen but contains 
proteoglycans and fibronectin.  The hypercellular keratocytes can be stimulated 
by IGF-I or PDGF to become collagenous keratocytes and synthesize a normal 
collagenous matrix abundant in collagen type Ι and keratocan.  In this case, 
collagenous keratocytes eventually become quiescent.  Hypercellular keratocytes 
can also be stimulated by TGF-β1to become fibrocollagenous keratocytes and 
produce an ECM scar, rich in EDA fibronectin, biglycan, and hyaluronan.  In 
addition, without subsequent activation by other growth factors, hypercellular 
keratocytes can remain hypercellular, which give rise to a hypercellular scar. 
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Abstract 
The transparency of the corneal stroma extracellular matrix (ECM) is 
attributed to the unique arrangement and size of the collagen fibrils.  Previous 
studies have shown that the processing of procollagen to collagen fibrils by 
keratocytes cultured in insulin is enhanced by an agarose overlay.  We compared 
collagen processing by keratocytes treated with IGF-I, TGF-β, FGF-2, and PDGF 
in cultures with or without an agarose overlay. 
Collagenase-isolated bovine keratocytes from bovine corneas were plated 
at 40,000 cells/cm2 and then cultured with DMEM/F12 alone, or DMEM/F12 
supplemented on day 4 with either 10ng IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng 
PDGF/ml.  Cultures were maintained as standard cultures or overlayed with 
~1mm of 3% agarose on day 6 and harvested for analysis on days 20.  Pepsin 
digestion and was used to determine procollagen deposited into the media and 
collagen content of cell layer.  Distribution of collagen type I and fibronectin in the 
ECM of the agarose cultures was determined by immunofluorescence.  Collagen 
fibril size and orientation was evaluated by electron microscopy. 
Only 6% of the collagen was processed in standard cultures for 
keratocytes cultured in media containing IGF-I and PDGF, and the agarose 
overlay increased processing 6-fold to 31%.  Collagen processing for FGF-2 was 
at ~10% with or without agarose. TGF-β treated keratocytes processed 19% of 
the collagen in standard culture and agarose increased processing to 31% but it 
was not a significant increase.  Immunoflourescence staining for collagen type I 
and fibronectin in the ECM were in different patterns for all growth factors, which 
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suggests they do not co-distributed.  Electron microscopy showed that the FGF-2 
agarose cultures had little collagen fibrils and the keratocytes were in close cell 
contact while IGF-I, TGF-β, and PDGF agarose cultures had an extensive ECM 
with abundant collagen fibrils.  The results of this study indicate that the 
synthesis of procollagen and the processing of procollagen to collagen are 
independently regulated and growth factor specific. 
 
Introduction 
The avascular cornea functions as a major refractive element of the eye.  
The stroma is 90% of the thickness of the cornea and it consists of a uniquely 
transparent extracelllular matrix (ECM) and keratocytes.   The stromal ECM is 
comprised primarily of collagen types I and V that arranged in uniformly sized, 
and spaced fibrils with keratan sulfate proteoglycans (keratocan and lumican) or 
chondroitin sulfate proteoglycans (decorin) between the fibrils [54, 90-92].  The 
highly organized ECM is synthesized and secreted by keratocytes, which are 
dendritic in morphology and are sparsely scattered among the stroma [93, 94].  
The transparency of the cornea is due to the precise arrangement of the collagen 
fibrils in the ECM [55]. This arrangement can be disrupted and transparency can 
be compromised upon wounding [4, 5, 72]. 
Although the keratocytes readily proliferate and are biosynthetically active 
during corneal development, they exhibit a relatively low level activity in the adult 
cornea and are considered “quiescent” [7, 8, 66].  However, the keratocytes 
become active again when a wound occurs to the cornea stroma.  The 
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keratocytes damaged during wounding undergo apoptosis [66, 68].  Some of the 
viable remaining keratocytes are activated to proliferate and migrate to the 
wound site [66, 69, 95] to form regions of hypercellularity [70, 96, 97]; densely 
packed cells with only a sparse or “provisional” ECM.  The keratocytes can 
remain hypercellular, resulting in a hypercellular scar or, can go on to stratify by 
producing an extensive collagenous ECM that is either a normal ECM which 
restores transparency or an abnormal fibrotic ECM, which is opaque [4, 72, 98, 
99].  Thus, keratocytes first go through a proliferative, ECM deficient 
hypercellular phase that is then followed by either a collagenous phase or a 
fibrocollagenous phase that produces keratocyte stratifcation. 
We found that the phases of ECM synthesis seen during wound healing in 
vivo could be replicated by the action of FGF-2, IGF-I, TGF-β, and PDGF on 
keratocytes in vitro [100].  FGF-2 stimulated the highest level of proliferation and 
maintained proteoglycan synthesis but did not stimulate collagen synthesis.  IGF-
I, TGF-β, and PDGF, in contrast, stimulated high levels of collagen and 
proteoglycan synthesis.  TGF-β also stimulated hyaluronan, biglycan, and 
fibronectin synthesis, components of the fibrotic ECM.  Therefore, we proposed 
[100] that in wound healing; 1) FGF-2 would induce the hypercellular phase, 
producing the sparse, collagen deficient, provisional matrix, 2) the action of IGF-I 
and PDGF would then induce the collagenous phase, producing the normal 
stromal ECM that restores transparency or 3) the action of TGF-beta would 
induce the fibrocollagenous phase, producing the opaque ECM that causes 
blindness. 
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Collagen is first made as procollagen:  three polypeptides containing N- 
and C-terminal globular domains with glycine-rich central region that forms a 
triple helix [11].  In vivo, the globular domains are rapidly removed allowing the 
helical regions to associate and form collagen fibrils.  Fibroblasts in standard cell 
culture do not readily process procollagen to collagen [83].  As a result, the 
procollagen accumulates in the culture medium and very little collagen is 
assembled into an ECM associated with the cells.  We have found, however, that 
a 3% agarose overlay on keratocytes cultured in insulin increased collagen 
processing and the formation of an ECM associated with the  keratocytes  [84]. In 
the current study, we use this agarose overlay cell culture system to compare 
collagen processing and ECM assembly by keratocytes cultured in each of the of 
growth factors that induce the different phases of cornea stromal wound repair.   
 
Materials and Methods 
All chemicals and growth factors were purchased from Sigma-Aldrich (St. 
Louis, MO) unless otherwise stated.  CyQuant kit, DMEM F/12, polyacrylamide 
gels, as well as pre-cast polyacrylamide gels and reagents that were used for 
protein separation and transfer were purchased from Invitrogen (Carlsbad, CA) 
and ECL Western blot analysis system was purchased from GE Healthcare 
(Piscataway, NJ).  Costar cell culture plates, nunc 96 well plate and chamber 
slides were purchased from Fisher Scientific (Suwanee, GA).  Rabbit polyclonal 
antibodies to collagen type I were obtained from Cosmo Bio Co. (Tokyo, Japan) 
and to fibronectin from Chemicon International (Temecula, CA).  FITC 
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conjugated anti rabbit antibodies were obtained from Novus Biologicals (Littleton, 
CO).  A mouse monoclonal antibody to fibronectin and an alkaline phosphotase 
conjugated goat anti mouse second antibody was purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA) for use in enzyme-linked immunosorbent assay.    
 
Keratocytes isolation and culture  
Bovine eyes harvested from 12-month calves were purchased from Pel 
Freeze (Rogers, AR) and keratocytes were isolated as previously described [50].  
Briefly, corneas were removed and keratocytes isolated by using two sequential 
collagenase digestions.  The culture medium used throughout was serum-free 
DMEM/F12 containing antibiotics and 1mM 2-phospho-ascorbic acid (DMEM).  
Cells were plated at ~400,000 cells/well in six well plates; ~200,000 cells/well in 
gelatin coated, 2-well slides; and ~1,000,000 cells/ 60 mm dish on day 0.  The 
medium was changed on day 4 with DMEM or to DMEM supplemented with 10ng 
IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng PDGF/ml.   
Keratocyte cultures were overlayed with 3% agarose in DMEM on day 0 
as previously described [84].  In brief, 3 grams of agarose in 50 mls of distilled 
water was autoclaved, cooled to 37 °C and mixed with an equal volume of 37°C 
2x DMEM.  The medium was removed from cultures and the cells were 
overlayed with a volume of 3% agarose sufficient to produce a layer ~1mm thick 
on top of the cells.  The agarose was allowed to solidify at room temperature.  
DMEM supplemented with 10ng IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng 
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PDGF/ml was then added to the respective wells. Cultures were harvested on 
day 20 without intervening media changes. 
 
DNA measurement 
DNA was extracted from the cell layers of each well of harvested cultures 
using the buffer supplied in a Cyquant Assay Kit and the DNA measured using 
methods provided with the kit.  Calf thymus was used as a standard. 
 
Collagen measurement 
Medium and cell layer of cultures were pepsin digested as previously 
described [84, 100] to isolate collagen.  Briefly, eight milliliters of culture medium 
from a single well of a six well plate was adjusted to 0.5 M acetic acid.  Eight 
milliliters of 0.5 M acetic acid was added to the corresponding well.  After 
samples were chilled to 4°C, 100 µl of 4mg/ml pepsin stock was added to the 
medium and to each well.  The samples were digested overnight at 4°C, 
neutralized to inactivate the pepsin, dialyzed against distilled water, lyophilized, 
and reconstituted in 100 µl of 1X LDS sample buffer (Invitrogen).  Samples of 10 
µl were reduced and electrophoresed on 3-8% tris-acetate gels.  Gels were 
soaked in Simply blue safe stain according to the manufacturer’s instructions 
(Invitrogen) to stain the collagen.  The lanes were scanned and the optical 
density of the α and β chains of collagen was measured using Quantity One. 
Collagen for use as standard in SDS/PAGE analysis, was also isolated 
from corneas by pepsin digestion, and specifically precipitated by dialysis against 
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cold distilled water.  The precipitated collagen was solubilized in 0.01N HCl and 
quantified by measuring its absorbance at 228 nN. 
 
Fibronectin measurement 
Fibronectin levels in the media were determined by enzyme-linked 
immunosorbent assay using 96 well nunc plates.  Media from cell cultures and 
fibronectin used as standard were coated on the wells in bicarbonate buffer.  The 
wells were blocked with phosphate buffered saline (PBS) containing 1% bovine 
serum albumin.  The primary and alkaline phosphotase conjugated second 
antibody was diluted in PBS with 0.5% tween-20.   P-nitophenyl phosphate in 
diethanolamine was used as a substrate for color development and optical 
density was measured at 405 nm in a 96 well plate reader. 
 
Fixation and immunohistochemistry 
Cells on glass slides were fixed in 4% paraformaldehyde in PBS for 1 hr 
and rinsed with 1% glycine.  The agarose layer was removed and nonspecific 
antigens were blocked with 2.5% BSA in PBS at room temperature.  Slides were 
then incubated with a rabbit anti-bovine collagen type I antibody at 1:500 or rabbit 
anti-bovine fibronectin at 1:1000 in dilution buffer (1% BSA, 1% Tween 20 in 1x 
PBS) for 2 hrs.  Unbound antibody was washed off with two 5-minute washes in 
PBS/Tween 20.  The primary antibodies were detected by FITC conjugated anti-
rabbit antibody at 1:500 in dilution buffer incubated for 1 hour in the dark.  
Afterward, slides were given two 5-minute washes with PBS in the dark.  Slides 
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were allowed to dry. Cover slips were mounted with DAPI mounting medium, 
which stain the nuclei of all cells.  Slides stained with the secondary antibody 
only were used to determine the levels of background fluorescence for recording 
digital images on slides stained with both primary and secondary antibodies.  
Positive controls were sections of fresh bovine corneal tissue. 
 
Fixation and electron microscopy 
Transmission electron microscopy was used to evaluate the organization 
of ECM deposited by keratocytes cultured under agarose.  Keratocytes cultured 
in 60mm plates were fixed in 2.5% glutaraldehyde, 4% paraformaldehyde, 0.1M 
sodium cacodylate, and 8.0 mM calcium chloride.  The agarose overlay was 
removed and cultures were post-fixed with 1% osmium tetroxide.   The samples 
were dehydrated with a graded series of ethanol/water solutions.  Cells were 
scrapped off the dish with a cell scraper, transferred to a 1.5ml tube, further 
dehydrated with pure propylene oxide and then infiltrated and embedded in a 
mixture of Embed 812, nadic methyl anhydride, dodecenylsuccinic anhydride and 
DMP-30 (Electron Microscopy Sciences, PA).   Sections of 90nm thickness were 
examined using a JEOL 1400 transmission electron microscope, and 
photographed with a Gatan Orius camera. 
 
Statistics 
All DNA and collagen values were the mean of 3 determinations. Statview 
Version 5 (SAS Institute, Cary, NC) was used for statistical comparisons.  
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Samples were analyzed using a paired t test and standard deviation was used 
when n=3.   
 
Results 
Keratocytes were cultured for days 4 to 20 in media containing IGF-I, 
TGF-β, FGF-2 or PDGF in standard culture and with an agarose overlay.  The 
cultures were harvested on day 20 and the fibrillar collagen deposited with the 
cell layer was solubilized by pepsin digestion.  The collagen in the pepsin 
digestion was measured by SDS/PAGE and the amount of collagen was 
expressed per DNA.  IGF-I and PDGF agarose cultures accumulated significantly 
more collagen with the cell layer in agarose cultures than in standard culture by 
2.8-fold (Fig. 15).  In contrast, standard and agarose keratocyte cultures treated 
with TGF-β and FGF-2 had similar levels of collagen associated with the cell 
layer, although TGF-β cultures accumulated significantly more collagen than 
FGF-2 by 6-fold.  These results indicate that the agarose overlay significantly 
enhanced collagen deposition with the cell layer in keratocytes cultured in media 
containing IGF-I and PDGF. 
In vivo, procollagen, a precursor of collagen is readily processed and 
subsequently assembled into mature collagen fibrils [11].  However, in standard 
cell culture, procollagen is not efficiently processed and it accumulates in the 
media as procollagen [83, 84].  We used pepsin digestion to convert the 
procollagen in the media to collagen to make it compatible with measurement of 
collagen levels in the cell layer.  Cultures treated with IGF-I, TGF-β, and PDGF 
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and overlayed with agarose had significantly lower (45-55% lower) levels of 
collagen in the media than the standard cultures (Fig. 16).  This indicates that 
procollagen secretion into the media was significantly reduced by the agarose 
overlay for keratocytes cultured in all growth factors except FGF-2. 
The amounts of collagen in the media and cell layers were then combined 
to determine total collagen produced in standard and agarose cultures treated 
with growth factors (Fig. 17).  Keratocytes cultured in media containing IGF-I, 
TGF-β, and PDGF produced significantly less (37-39% less) total collagen when 
overlayered with agarose.  This indicates that the agarose overlay significantly 
inhibits collagen synthesis in keratocytes cultured in all growth factors except 
FGF-2. 
 We next calculated the amount of collagen in the cell layer as a percent of 
the total collagen (cell layer and media) produced (Fig. 18).  The results show 
that keratocytes cultured in IGF-I and PDGF in standard culture converted ~6% 
of the total collagen produced to fibrillar collagen and this was increased to 31% 
(5 –fold) by agarose.  Keratocytes cultured in TGF-β in standard culture, 
however, converted significantly more (19%) than IGF-I and PDGF in standard 
culture and although the agarose increased conversion to 31% for TGF-β, it was 
not significantly more.  Thus, for keratocytes cultured in TGF-β, the agarose 
overlay did not significantly enhance procollagen conversion to collagen over that 
achieved in standard cultures because of the already high levels of conversion in 
standard culture.  Collagen conversion was at ~10% for FGF-2 treated cultures, 
with or without agarose.  These results indicate the synthesis of procollagen and 
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the processing of procollagen are independently regulated and growth factor 
specific. 
 Fibronectin is a component of the ECM that has a molecular weight similar 
to procollagen type I.  Therefore, we also measured the levels of fibronectin in 
the media of keratocytes treated with growth factors and cultured with and 
without agarose overlay (Fig. 19).  The levels of fibronectin in the media of 
keratocytes in standard culture containing PDGF and TGF-β was 5-fold and 38-
fold higher, respectively, than that for IGF-I or FGF-2 in standard culture.  
However, in contrast to that seen with the agarose-mediated reduction of 
procollagen in the media, agarose did not reduce the levels of fibronectin 
deposited into the media. 
 The distribution of collagen and fibronectin within the cell layer of the 
agarose cultures was determined by immunohistochemistry using rabbit 
antibodies to collagen type I and to fibronectin followed by a FITC labeled second 
goat anti rabbit antibody (Fig. 20).  Nuclei were stained with DAPI.  The location 
of the nuclei showed that keratocytes tended to cluster in aggregates when 
cultured in IGF-I but were more uniformly distributed when cultured in the other 
growth factors.  The antibody to collagen type I showed that collagen in IGF-I 
treated cultures were deposited in linearly connected clumps that corresponded 
with the cell aggregates.  The collagen deposited in the TGF-β treated cultures 
were distributed more uniformly in large homogenous patches.  Staining for 
collagen in FGF-2 treated cultures was almost non-existent.  The collagen in the 
PDGF treated cultures was deposited in both intensely staining clumps and in 
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faintly staining patches.  The antibody to fibronectin revealed fibronectin was 
distributed in both thick and thin linear tracks:  thick linear tracks in the IGF-I and 
PDGF treated cultures, much thinner and more homogeneously distributed linear 
tracks in the TGF-β treated cultures and both thick and thin linear tracks in the 
FGF-2 treated cultures.  Staining for fibronectin was clearly more extensive than 
the staining for collagen in the FGF-2 treated cultures. 
 The size and organization of the collagen fibrils in the ECM of the cell 
layer of agarose cultures was determined by transmission electron microscopy.  
There was extensive ECM space between cells in the IGF-I, TGF-β and PDGF 
treated cultures that was filled with collagen fibrils (Fig. 21).  The diameter of 
fibrils in the TGF-β treated culture were approximately one half the diameter and 
were more uniformly oriented than that seen in IGF-I treated cultures.  The fibrils 
in the PDGF treated cultures showed the characteristics seen in both the TGF-β 
and IGF-I cultures.  There was only limited ECM space in the FGF-2 treated 
cultures.  The keratocytes were densely packed together and the collagen fibrils 
in the space between the cells were sparse.  The cell surfaces in FGF-2 treated 
cultures showed extensive regions of cell-cell contact. 
 
Discussion 
 The results of these studies shows that compared to standard cultures, 
the agarose overlay enhanced collagen accumulation associated with the cell 
layer of keratocytes cultured in media containing IGF-I and PDGF but not in 
keratocytes cultured in TGF-β.  TGF-β, IGF-I and PDGF, all stimulated collagen 
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synthesis in standard cultures [100].  The results of the current study, however, 
show TGF-β treated keratocytes to be more efficient at processing procollagen to 
collagen in standard culture than IGF-I or PDGF and this may account for the 
lack of an enhancing effect of the agarose overlay on TGF-β treated keratocytes.  
The accumulation of collagen associated with the cell layer was also not 
enhanced by the agarose overlay of the FGF-2 treated cultures.  FGF-2, 
however, does not stimulate collagen synthesis in standard culture [100].  This 
suggests that the agarose overlay only can enhance collagen processing when 
collagen synthesis is stimulated by some growth factors. 
 TGF-β has previously been shown to enhance the proliferation and cell 
stratification of human fibroblast in standard culture and in media containing fetal 
bovine serum [101] and these antibodies to fibronectin could inhibit both the 
basal levels and TGF-β stimulated levels of proliferation and stratification.  We 
found TGF-β stimulated fibronectin synthesis 5 and 20-fold greater than that of 
PDGF and IGF-I, respectively and that the distribution of fibronectin in the ECM 
of the TGF-β treated cultures, as determined by immunoflourescent staining, was 
distinctively different than that of the IGF-I and PDGF treated cultures.  
Fibronectin has been shown to play an essential role in the assembly of collagen 
types I and III fibrils [102, 103].  The high levels of fibronectin production seen in 
TGF-β treated cultures and its unique distribution may be responsible for the high 
levels of procollagen to collagen conversion seen in the TGF-β treated 
keratocytes in standard culture. 
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 The agarose overlay reduced the levels of procollagen, but not the levels 
of fibronectin in the media of keratocytes cultured in media containing IGF-I, 
TGF-β, and PDGF.  We previously proposed [84] that the agarose overlay may 
be acting as a semi permeable barrier, or molecular sieve, to retard the diffusion 
of procollagen into the media and increase its concentration at the cell surface 
where the enzymes are that remove the N- and C-terminal globular domains from 
the procollagen.  Fibronectin and procollagen have similar molecular weights and 
the differential effect that the agarose has on their diffusion into the media would 
suggest that the agarose is not acting as a molecular sieve.   
 The immunostaining for collagen and fibronectin showed they were 
deposited with the cell layer in distinctly different patterns for each of the growth 
factors.  The keratocytes cultured in IGF-I formed aggregates and collagen was 
deposited in clumps while the fibronectin was in thick tracks associated with 
these cell aggregates.  In contrast, the collagen was deposited in large patches 
and the fibronectin in thin tracks and both were more uniformly distributed in cell 
layer of keratocytes cultured in TGF-β.  The pattern of collagen distribution in the 
PDGF treated cultures was intermediate between that seen in the IGF-I and 
TGF-β treated cultures.  Similarly, the pattern of distribution of fibronectin 
deposited in the PDGF treated cultures also had characteristics of both the IGF-I 
and TGF-β cultures:  it was distributed throughout the culture, but it was in thick 
bands, like the IGF-cultures.  Fibronectin distribution is the FGF-2 treated 
cultures was considerably more extensive than that of collagen.  These 
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observations suggest that the collagen and fibronectin deposited in the ECM of 
these cultures do no co-distribute.   
 Electron microscopy revealed differences in the collagen fibrils that were 
deposited in the ECM by keratocytes cultured in the different growth factors.  The 
fibrils in the IGF-I treated cultures were organized in lamellae while the fibrils in 
the TGF-β treated cultures were thinner and were more uniformly oriented.  
Although there was abundant fibril deposition in the IGF-I, TGF-β, and PDGF 
treated cultures, there was only a few fibrils seen in the FGF-2 treated cultures.  
In the FGF-2 treated cultures, the keratocytes were densely packed together with 
extensive close cell contacts, leaving little space for an ECM. This is similar to 
that seen for keratocytes in the hypercellular phase of corneal stromal wound 
healing. 
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Figure 15.  Collagen levels associated with the cell layer of keratocytes in 
standard and in agarose culture.  Keratocytes were cultured in media 
containing IGF-I, TGF-β, FGF-2, or PDGF and harvested for analysis on 
day 20.  Agarose overlay significantly enhanced collagen accumulation in 
keratocytes cultured in IGF-I and PDGF by 2.8 fold.   TGF-β and FGF-2 
agarose cultures had similar levels of collagen in the cell layer as the 
standard cultures. 
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Figure 16. Collagen levels in the media of keratocytes in standard and in 
agarose culture. Keratocytes were cultured in media containing IGF-I, TGF-β, 
FGF-2, or PDGF and harvested for analysis on day 20.  Keratocytes cultured 
in media containing IGF-I, TGF-β, and PDGF and under agarose deposited 
significantly less collagen into the media than in parallel standard cultures. 
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Figure 17.  Collagen levels associated with the cell layer and media combined 
of keratocytes in standard and in agarose cultures.  Keratocytes were cultured 
in media containing IGF-I, TGF-β, FGF-2, or PDGF and harvested on day 20.  
IGF-I, TGF-β, and PDGF agarose cultures produced significantly less total 
collagen than standard cultures. 
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Figure 18.  Procollagen to collagen conversion rates for keratocytes in standard 
and agarose cultures.  Collagen amounts associated with the cell layer (Figure 1) 
were divided by the amounts in the cell layer and media combined and expressed 
as a percent.  Compared to standard cultures, agarose significantly enhanced 
procollagen conversion to collagen in cultures treated with IGF-I and PDGF by 6-
fold.  TGF-β treated standard cultures were significantly more efficient at 
converting procollagen to collagen then IGF-I and PDGF standard cultures by ~3-
fold. 
67 
 
Figure 19.  Fibronectin levels in the media of keratocytes in standard and 
agarose cultures.  Keratocytes were cultured in media containing IGF-I, TGF-
β, FGF-2, or PDGF and harvested for analysis on day 20.  In standard 
cultures, keratocytes cultured in TGF-β accumulated ~20-fold more fibronectin 
in the media than IGF-I and FGF-2 cultures and 5-fold more fibronectin in the 
media than PDGF cultures.  However, compared to standard culture, agarose 
had no effect on the deposition of fibronectin into the media. 
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 Figure 20.  Immunofluorescent staining of the cell layers of keratocytes cultured 
under agarose.  Keratocytes were cultured in media containing IGF-I (I), TGF-β 
(T), FGF-2 (F), or PDGF (P) and stained with antibodies to either collagen (c) or 
fibronectin (f) on day 20.  Nuclei were stained with DAPI.  Collagen was 
distributed in clumps and in large patches while fibronectin was distributed in 
thick and thin tracks. 
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Figure 21.  Electron microscopy of the cell layers of keratocytes cultured under 
agarose.  Keratocytes were cultured in media containing IGF-I (I), TGF-β (T), 
FGF-2 (F), or PDGF (P) and fixed for electronmicroscopy on day 20.  Collagen 
fibrils were abundant in the ECM of the IGF-I TGF-β, and PDGF treated cultures 
while FGF-2 treated cultures exhibited only little ECM with few collagen fibrils. 
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Chapter Four 
 
Expansion of Primary Cultures of Keratocyte with Retention of Native 
Phenotype 
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Introduction 
The stroma is the thickest layer of the cornea and consists of a 
transparent ECM, comprised mainly of proteoglycans and fibrillar collagens [2].  
The ECM is synthesized and secreted by keratocytes.  In a mature cornea, 
keratocytes are quiescent and dispersed among the stroma, possessing a 
dendritic morphology and elevated levels of two keratan sulfate proteoglycans:  
lumican and keratocan.  These cells also express crystallins, high levels of 
aldehyde dehydrogenase (ALDH) and transketolase, which contribute to the 
transparency of the cornea [4, 104, 105].  The expression of keratocan and high 
levels of ALDH are unique to keratocytes and they are considered markers of 
their native phenotype. 
The standard culture medium for keratocytes in culture is DMEM/F12 
containing 5-10% fetal bovine serum.   Fetal bovine serum causes the 
keratocytes proliferate and to differentiate into fibroblasts or myofibroblasts [81, 
106, 107].  These cells are characterized by their spindle-like morphology, 
increased rate of proliferation and expression of fibronectin, hyaluronan, and 
alpha-smooth muscle actin, and decreased expression of keratan sulfate 
proteoglycans and aldehyde dehydrogenase (ALDH) [80, 88, 106].  It has been 
suggested that the corneal fibroblasts and myofibroblasts are not terminally 
differentiated and can return to the keratocyte phenotype [108].  
Considering the wide spread use of corneal fibroblasts in vision research, 
it would be useful if there was a simple way to restore the keratocyte phenotype 
to these differentiated cells.  Studies have shown that human keratocytes can 
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retain their native morphology and keratocan expression in the presence of FBS, 
when cultured on an amniotic membrane [109].  Other studies have shown that 
KS synthesis and a dendritic morphology but not ALDH content could be restored 
to bovine corneal fibroblasts by switching to serum-free medium [110].  
Additionally, keratocytes isolated from human corneas, cultured in a special stem 
cell medium and selected for a stem cell marker protein become fibroblastic, but 
keratan sulfate, keratocan, and ALDH expression could be restored in these cells 
by subsequent culture in medium containing FGF-2 and ITS (Insulin, Transferrin, 
and Selenium) [111].  
In this study, we investigated the effect of media containing either insulin, 
ITS, or FGF-2 alone or in combination, on the proliferation and restoration of 
keratocan by bovine and human keratocytes.  We expect FGF-2 to significantly 
stimulate proliferation and ITS and insulin to stimulate keratocan production. 
 
Materials and Methods 
The materials and methods used are the same as in Chapter 2. 
 
Results and Discussion 
We attempted to grow and pass primary bovine keratocytes by culture in 
medium containing either insulin, ITS, FGF-2, or FGF-2 with insulin or ITS.  We 
found that keratocytes cultured in insulin and ITS could not be removed from the 
culture plate by standard trypsin digestion.  Keratocytes cultured in FGF-2 
proliferated and were efficiently removed and passed, but proliferation 
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discontinued after the first or second passage.  FGF-2 treated keratocytes 
possessed spindled-shape morphology.  Keratocytes cultured in FGF-2 
combined with insulin or ITS, however, could be repeatedly passed using trypsin 
digestion and replated. These cells continued to proliferate and retained their 
dendritic morphology when cultured in insulin or ITS. 
Therefore, we cultured bovine keratocytes in media containing FGF-2 
combined with ITS and passed them 4 times at low density.  Keratocytes were 
then evaluated for their ability to proliferate and produce keratocan by 
subsequent culture for 6 days in media insulin, ITS, or FGF-2 alone or in 
combination.  The results showed that compared to control, the DNA content of 
the keratocytes cultured in FGF-2 alone increased 24% and the DNA content of 
the cultures in FGF-2 combined with either insulin or ITS increased 1.6 fold (Fig. 
22A). 
Media samples were digested with endo β galactosidase to remove the 
KS chains from KSPG’s.  Then, digested media was DNA-normalized and levels 
of keratocan core protein were measured by Western blot using an antibody to 
keratocan (Fig. 22B).  The results showed that both the control and the FGF-2 
treated cultures expressed low levels of keratocan while cultures in FGF-2 plus 
insulin or plus ITS expressed higher levels but cultures in insulin or in ITS alone 
expressed the highest levels. The keratocytes cultured in insulin or in ITS also re-
acquired a dendritic morphology (data not shown). This suggests that 
keratocytes maintain keratocan expression after growth and passage in media 
containing FGF-2 plus ITS.  Additionally, keratocytes subsequently cultured in 
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insulin or ITS further enhances keratocan expression as well as their dendritic 
morphology.  
We next determined if keratocan could be restored to cultured bovine 
keratocytes passed in fetal bovine serum by subsequent culture in insulin and 
ITS alone or in combination with FGF-2.  Therefore, we grew keratocytes in 
media containing 2.5% FBS and they possessed myofibroblast-like morphology. 
The keratocytes were passed 6 times, and plated them at low density.  We then 
tested their ability to proliferate (Fig. 23A) and produce keratocan (Fig. 23B) by 
subsequent culture in media with and without growth factors for 6 days.  
Compared to control, the DNA content of the cultures treated with FGF-2 alone 
increased 22%.  The DNA content of the cultures treated with FGF-2 combined 
with insulin increased 1.4-fold, while the DNA content of cultures treated with 
FGF-2 combined with ITS increased 5-fold.   Levels of keratocan were evaluated 
as previously described.  We found that the control and the FGF-2 treated 
cultures contained undetectable levels of keratocan.  Cultures treated with insulin 
alone, ITS alone, and FGF-2 combined with ITS contained readily detectable 
levels of keratocan.  The keratocytes cultured in insulin alone and ITS alone 
reacquired a dendritic morphology (data not shown). This data showed that 
keratocan synthesis and a dendritic morphology can be restored to keratocytes 
passed in FBS by subsequent culture in insulin or ITS. 
We next isolated human keratocytes from human corneas and cultured 
them in medium containing FGF-2 and ITS.  When the human keratocytes are 
plated and allowed to attach, they possess a dendritic morphology.  Unlike 
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bovine keratocytes, the human keratocytes become spindled-shaped after being 
cultured in media containing FGF-2 and ITS and passed only once.  Thus, while 
we were able to grow and pass these human keratocytes in this defined culture 
medium, we were unable to detect keratocan by western blot, a hallmark of 
native keratocytes.   
To assure that our antibodies to keratocan reacted with human keratocan 
if present, we extracted keratocan from human corneas and tested the antibodies 
by western blot.  We found that both the antibody to bovine keratocan and the 
antibody we purchased to human keratocan reacted with human keratocan core 
protein.  Therefore the failure to detect keratocan in media from cultured human 
keratocytes is not due to faulty antibodies.  The human corneas were from 16, 
17, and 42-year-old donors, while the bovine corneas were taken from 1-2 
year(s) old cattle.  Thus, it may be necessary to isolate keratocytes from corneas 
of younger human donors in order to successfully culture human keratocytes that 
maintain their in vivo phenotype. 
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Figure 22. Cell growth and keratocan expression by cultures derived from 
passed keratocytes.  Primary cultures of bovine keratocytes were grown and 
passed 4 times in media containing FGF-2 plus ITS.  The keratocytes were 
then plated at low density and cultured in media containing either FGF-2, 
insulin, ITS, insulin + FGF-2, or ITS + FGF-2 for 6 days.  A:  DNA content of 
cell layer.  B:  Western blot of endo-β- galactosidase digests of media using 
an antibody to keratocan core protein. 
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Figure 23.  Cell growth and keratocan expression by cultures derived from 
passed corneal fibroblasts.  Primary cultures of bovine keratocytes were 
grown and passed 6 times in media containing 2.5% FBS.  The corneal 
fibroblasts were then plated at low density in media containing either FGF-2, 
insulin, insulin + FGF-2, ITS, or ITS + FGF-2 for 6 days.  A:  DNA content of 
cell layer.  B: Western blot of endo-β- galactosidase digests of media using 
an antibody to keratocan core protein.  
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Chapter Five 
Conclusions and Future Directions 
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When the corneal stroma is wounded the keratocytes become activated 
by specific growth factors to proliferate, form regions of hypercellularity (densely 
packed cells with little extracellular matrix), and then go on to stratify by 
producing an extensive collagenous matrix.  These growth factors are made by 
macrophages, lymphocytes, and keratocytes themselves.  Additionally, growth 
factors have also been found to be present in tear film, aqueous fluid, and 
epithelium layer of the cornea.  Studies have shown that TGF-β is the key growth 
factor that aids in wound healing and causes the formation of a scar.  We have 
found that other growth factors such as, IGF-I, FGF-2, and PDGF are also 
important during the corneal wound healing process in vitro. 
We grew keratocytes in standard culture and in standard culture with an 
agarose overlay.  The agarose overlay enhanced the conversion of procollagen 
to collagen (Fig. 24), thereby increasing the deposition of collagen fibrils with the 
cell layer.  We postulated that the agarose overlay was acting as a molecular 
sieve.  There is no agarose present in vivo, however, the basement membrane 
that is made by the corneal epithelium is similar in structure and is likely to have 
the same function as the agarose overlay in vitro.   
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Keratocytes were cultured in media containing IGF-I, TGF-β, FGF-2, and 
PDGF and compared their ability to stimulate cell proliferation and extracellular 
matrix (ECM) synthesis.  Distribution and orientation of specific ECM proteins 
synthesized by keratocytes cultured in media containing IGF-I, TGF-β, FGF-2, 
and PDGF was evaluated by overlaying cells with agarose.  We found that FGF-
2 stimulated the highest level of proliferation but did not stimulate collagen 
synthesis.   FGF-2 treated keratocytes were in close cell contact. Therefore we 
speculated that FGF-2 signaling is associated with the hypercellular phase of 
corneal wound healing. 
IGF-I, TGF-β, and PDGF all stimulated proliferation and collagen 
synthesis.  TGF-β also stimulated the highest levels of EDA fibronectin, collagen 
type III, hyaluronan, and biglycan, markers of the abnormal fibrotic ECM.  IGF-I 
and PDGF cultures mostly stimulated collagen type I and keratan sulfate 
proteoglycans.  TGF-β, IGF-I, and PDGF are likely to be involved in the 
Figure 24.  Agarose overlay enhances the conversion of procollagen to collagen. 
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remodeling and stratification phase of corneal wound healing.  Presumably, IGF-I 
and PDGF are responsible for the restoration of a normal collagenous ECM, 
where as TGF-β is involved in the formation of a collagenous scarred ECM.  This 
sequential action of growth factors is depicted in (Fig. 25). 
 
 
 
 
 
 
Figure 25.  Proposed sequential action of growth factors to produce the phases 
of wound healing 
 
 
 
  
Taken together, the data in this dissertation should help to explain the role 
of growth factors in the corneal wound healing process. We have discovered that 
IGF-I, TGF-β, FGF-2, and PDGF are likely responsible for stimulating the 
different phases of corneal wound healing in vivo based on keratocyte 
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morphology and extracellular matrix production. Therefore, we can possibly 
direct keratocytes to make a normal collagenous ECM upon wounding by 
manipulating the levels of growth factors during specific phases of corneal wound 
repair.  As a result, we can reduce corneal opacity caused by scarring.  
Additionally, these growth factors can be used to stimulate keratocytes to 
produce collagen, in collagen-depleted corneas of keratoconus patients.  
Therefore, this dissertation is clinically relevant and a significant addition to the 
scientific literature. It serves to identify novel targets for treatment of corneal 
scarring and keratoconus. 
To further this study, we plan to evaluate the levels of these growth factors 
in each phase of the corneal wound healing process in vivo.  Then, inhibit select 
growth factors or use knockout animals to determine the effect on the 
morphology of keratocytes and the ECM components.  Additionally, we plan to 
use the newly established agarose cell culture system to further visualize the 
corneal stroma ECM in vitro.  More specifically, the agarose cell culture system 
will be used to further study the interactions between keratocytes and their 
surrounding extracellular matrix as well as to determine the expression of growth 
factor receptors during each phase of corneal wound healing. 
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Appendix A 
Pepsin readily degrades globular proteins, but the triple helical domains of 
collagen are resistant to this protease.  Aliquots of pepsin digested media and 
cell layers, normalized for DNA, harvested from the day 7, 10, and 13 time points 
were fractionated on SDS/PAGE and the collagenous proteins visualized by 
simply blue staining (Fig. 26).  Similar to that seen for the proteoglycans, the 
media (M) from the IGF-1 cultures contained substantially higher amounts of the 
a1(I), a2(I) and a1(V) chains of collagen than the control cultures and media from 
the days 10 and 13 insulin cultures contained slightly higher levels of these 
collagens than the IGF-1 cultures.  This data demonstrate that insulin and IGF-I 
stimulate keratocytes to synthesize similar levels of collagen.  
 
Figure 26. SDS/PAGE/Blue stain of pepsin digests from keratocyte cultures. 
Keratocytes were cultured in media alone (C) or in media containing either IGF-I 
(IG) or insulin (IN).  Cultures were harvested on day 7, 10, and 17.  The media 
(M) and cell layers (CL) were digested with pepsin prior to electrophoresis.
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